Huawei Diabetes Risk assessment has arrived as the tech giant showcased its latest wearable-based blood sugar management wellness trend insights at the World Health Expo Dubai 2026. The innovative feature uses non-invasive Photoplethysmography (PPG) technology with advanced sensors on Huawei smartwatches to monitor users’ PPG data and provide proactive wellness alerts based on collected information.
The feature is designed to raise awareness about potential diabetes risks and encourage users to seek early medical intervention. This development comes at a critical time when diabetes continues to affect millions globally, with many cases remaining undiagnosed until complications arise.
Global Diabetes Crisis Demands Innovation
According to the 2024 report by the International Diabetes Federation (IDF), 589 million adults aged 20 to 79 have diabetes worldwide. The statistics reveal a concerning reality: 43% of all people living with diabetes are undiagnosed, and 81% live in low- and middle-income countries.
In the MENA region, 85 million adults are living with diabetes, a number expected to increase by 92% to 163 million by 2050. The UAE faces a particularly high prevalence rate of 20.7% among the adult population, making innovative monitoring solutions increasingly essential.
How Huawei Diabetes Risk Assessment Works
Recent breakthroughs in research have found a shared genetic aetiology between resting heart rate and diabetes. Similarly, diabetes-related microvascular arteriosclerosis and neuropathy have been found to affect PPG signals. Given the multitude of mechanisms by which diabetes impacts PPG, Huawei developed this feature to identify blood sugar fluctuations based on PPG measurements using smartwatches.
Users must consistently wear the watch on their wrist for 3 to 14 days. Upon completion, the Diabetes Risk app categorizes wellness patterns into Low, Medium, or High. Huawei recommends that users categorized as Medium and High patterns seek professional medical help for further diagnosis.
Expert Collaboration and Scientific Validation
“Wearable-based PPG technology represents a reliable method for proactive health-trend awareness”
Professor Jiguang Wang, Director of the Shanghai Institute of Hypertension
Professor Wang has collaborated with Huawei to advance wearable health management. He played a key role in the development of the HUAWEI WATCH D, Huawei’s first blood pressure monitoring smartwatch, and the subsequent HUAWEI WATCH D2.
Availability and Future Expansion
Huawei has already made the feature available on the HUAWEI WATCH GT 6 Pro through an OTA update. Wider compatibility across more smartwatch models is on the horizon. While the feature is safe for all users and has no side effects or contraindications, it is not a replacement for professional diabetes diagnostics.
This empowers individuals to prioritize preventative care and helps users recognize potential wellness trends early and seek expert advice in a timely manner. The feature shall not be confused with detecting precise blood glucose levels or diagnosis, but rather serves as an early warning system for potential health concerns.
